These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 24895114

  • 1. Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy.
    May M, Brookman-May S, Burger M, Gilfrich C, Fritsche HM, Rink M, Chun F, Fisch M, Roghmann F, Noldus J, Mayr R, Pycha A, Novotny V, Wirth M, Vallo S, Haferkamp A, Roigas J, Brisuda A, Stredele R, Volkmer B, Dechet C, Schnabel M, Denzinger S, Stief CG, Bastian PJ, Aziz A.
    Ann Surg Oncol; 2014 Nov; 21(12):4034-40. PubMed ID: 24895114
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder.
    Vallo S, Gilfrich C, Burger M, Volkmer B, Boehm K, Rink M, Chun FK, Roghmann F, Novotny V, Mani J, Brisuda A, Mayr R, Stredele R, Noldus J, Schnabel M, May M, Fritsche HM, Pycha A, Martini T, Wirth M, Roigas J, Bastian PJ, Nuhn P, Dahlem R, Haferkamp A, Fisch M, Aziz A.
    Urol Oncol; 2016 Oct; 34(10):432.e1-8. PubMed ID: 27283218
    [Abstract] [Full Text] [Related]

  • 3. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 4. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
    Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG, Rink M, Chun FK, Fisch M, Novotny V, Froehner M, Wirth MP, Schnabel MJ, Fritsche HM, Burger M, Pycha A, Brisuda A, Babjuk M, Vallo S, Haferkamp A, Roigas J, Noldus J, Stredele R, Volkmer B, Bastian PJ, Xylinas E, May M.
    BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
    [Abstract] [Full Text] [Related]

  • 5. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
    May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M.
    Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
    [Abstract] [Full Text] [Related]

  • 6. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, Lerner SP, Sonpavde G, Sagalowsky AI, Gupta A.
    BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
    [Abstract] [Full Text] [Related]

  • 7. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement.
    Pagano F, Bassi P, Ferrante GL, Piazza N, Abatangelo G, Pappagallo GL, Garbeglio A.
    J Urol; 1996 Jan; 155(1):244-7. PubMed ID: 7490845
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
    Mitra AP, Alemozaffar M, Harris BN, Schuckman AK, Skinner EC, Daneshmand S.
    Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
    [Abstract] [Full Text] [Related]

  • 10. Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder.
    Daneshmand S, Stein JP, Lesser T, Quek ML, Nichols PW, Miranda G, Cai J, Groshen S, Skinner EC, Skinner DG.
    J Urol; 2004 Jul; 172(1):81-4. PubMed ID: 15201742
    [Abstract] [Full Text] [Related]

  • 11. Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma.
    Patel AR, Cohn JA, Abd El Latif A, Miocinovic R, Steinberg GD, Paner GP, Hansel DE.
    J Urol; 2013 Jan; 189(1):53-8. PubMed ID: 23164389
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.
    Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A, Burger M.
    Eur Urol; 2013 Apr; 63(4):739-44. PubMed ID: 23079053
    [Abstract] [Full Text] [Related]

  • 13. Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy.
    Knoedler JJ, Boorjian SA, Tollefson MK, Cheville JC, Thapa P, Tarrell RF, Frank I.
    BJU Int; 2014 Dec; 114(6):832-6. PubMed ID: 24119219
    [Abstract] [Full Text] [Related]

  • 14. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 15. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 16. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
    Rieken M, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Faison T, Lotan Y, Karakiewicz PI, Sun M, Fajkovic H, Babjuk M, Bachmann A, Scherr DS, Shariat SF.
    Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
    [Abstract] [Full Text] [Related]

  • 17. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M, Helke C, Nitzke T, Vogler H, Hoschke B.
    Urol Int; 2004 Jan; 72(2):103-11. PubMed ID: 14963349
    [Abstract] [Full Text] [Related]

  • 18. Outcome in patients with seminal vesicle invasion after radical cystectomy.
    Volkmer BG, Küfer R, Maier S, Bartsch G, Bach D, Hautmann R, Gschwend JE.
    J Urol; 2003 Apr; 169(4):1299-302. PubMed ID: 12629347
    [Abstract] [Full Text] [Related]

  • 19. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS.
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.